Entera Bio News - ENTX

Company Name	Stock Ticker Symbol	Market	Type
Entera Bio Ltd	ENTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.25	-11.16%	1.99	19:59:27

Open Price	Low Price	High Price	Close Price	Prev Close
2.24	1.95	2.29	1.99	2.24

more quote information »

Recent News

Date	Time	Source	Heading
4/08/2024	08:30	GLOBE	Entera Bio Announces Publication of Oral PTH(1-34) Peptide..
3/26/2024	08:30	GLOBE	Entera Bio Announces Key Regulatory Milestone for Oral..
3/20/2024	08:00	GLOBE	Entera Bio Announces Robust Pharmacokinetic Data for..
3/08/2024	16:25	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/08/2024	16:12	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/08/2024	16:10	EDGAR2	Form 8-K - Current report
3/08/2024	16:05	GLOBE	Entera Bio Announces Full Year 2023 Financial Results and..
3/04/2024	08:30	EDGAR2	Form 8-K - Current report
3/04/2024	08:30	GLOBE	Entera Bio Regains Compliance with Nasdaq Minimum Bid Price..
2/15/2024	17:10	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/15/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/14/2024	06:05	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
2/02/2024	16:19	EDGAR2	Form 8-K - Current report
2/02/2024	16:17	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/30/2024	08:30	GLOBE	Entera Bio to Present at the Oppenheimer 34th Annual..
1/16/2024	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/11/2024	18:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	18:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	08:00	EDGAR2	Form 8-K - Current report
12/27/2023	08:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	08:00	EDGAR2	Form 8-K - Current report
12/26/2023	08:00	GLOBE	Entera Bio Announces Closing of Private Placement - Extends..
11/29/2023	08:30	GLOBE	Interim Results from Ongoing Clinical Study Confirm EB613..
11/14/2023	07:30	GLOBE	Entera Bio Reports Q3 2023 Financial Results, Highlights..
11/09/2023	14:30	GLOBE	Entera Bio Reports Key Milestone Relating to Oral PTH (1-34)..
10/16/2023	08:00	GLOBE	Entera Bio Reports Rapid Pharmacodynamic (PD) Response and..
9/14/2023	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/14/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	16:05	EDGAR2	Form 8-K - Current report
9/12/2023	08:30	GLOBE	Entera Bio Announces Collaboration with OPKO Biologics to..
9/05/2023	08:00	GLOBE	Entera Bio to Participate in Upcoming Investor Conferences
8/24/2023	08:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/24/2023	08:11	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/22/2023	09:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/16/2023	08:30	GLOBE	Entera Bio to Present Two Abstracts on its First-in-Class,..
8/15/2023	16:10	EDGAR2	Form DEF 14A - Other definitive proxy statements
8/11/2023	16:19	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	16:16	EDGAR2	Form 8-K - Current report
8/11/2023	16:05	GLOBE	Entera Bio Announces Q2 2023 Financial Results and Corporate..
6/30/2023	16:06	EDGAR2	Form 8-K - Current report
6/07/2023	07:30	GLOBE	Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its..
5/05/2023	16:05	GLOBE	Entera Bio Announces Q1 2023 Financial Results and Corporate..
5/03/2023	09:34	GLOBE	Entera’s Oral Delivery of GLP-2 Pre-Clinical Data to be..
4/26/2023	08:30	GLOBE	Menopause Luminary, Dr. Steven R. Goldstein, Joins Entera’s..